Cargando…

Does HIF-PHI increased risk of gastrointestinal hemorrhage in patients with renal anemia: a review of cases reported to the U.S. Food and drug administration adverse event reporting system

Detalles Bibliográficos
Autores principales:	Zhou, Yangzhong, Ren, Qidong, Hu, Rongrong, Zheng, Ke, Qin, Yan, Li, Xuemei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330797/ https://www.ncbi.nlm.nih.gov/pubmed/34315325 http://dx.doi.org/10.1080/0886022X.2021.1952881

Ejemplares similares

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
por: Bai, Xiaoyin, et al.
Publicado: (2021)

Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System
por: Jones, S. Christopher, et al.
Publicado: (2015)

U.S. Health Resources & Services Administration
por: Washko, Michelle M.
Publicado: (2022)

Cutaneous Toxicity Associated With Enfortumab Vedotin: A Real-Word Study Leveraging U.S. Food and Drug Administration Adverse Event Reporting System
por: Yang, Hui, et al.
Publicado: (2022)

Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System
por: Li, Xiaotong, et al.
Publicado: (2023)

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
por: Dores, Graça M., et al.
Publicado: (2019)

The frequencies and disparities of adverse childhood experiences in the U.S.
por: Giano, Zachary, et al.
Publicado: (2020)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
por: Su, Si, et al.
Publicado: (2023)

Associations of low-carbohydrate with mortality in chronic kidney disease
por: Ren, Qidong, et al.
Publicado: (2023)

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
por: Learned, Christine, et al.
Publicado: (2022)

Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS)
por: Hoffman, Keith B., et al.
Publicado: (2014)

WITHDRAWN: A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products
por: Rose, Jessica, et al.
Publicado: (2021)

Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis
por: Zhou, Zeyun, et al.
Publicado: (2020)

Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
por: Wei, Shaokui, et al.
Publicado: (2021)

Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration
por: Lipner, Shari R., et al.
Publicado: (2020)

Safety analysis of pemigatinib leveraging the US Food and Drug administration adverse event reporting system
por: Zhang, Ying, et al.
Publicado: (2023)

The production of $\phi$ in 200 GeV/nucleon S - U and O - U interactions
por: Baldisseri, Alberto
Publicado: (1990)

Chronic Kidney Diseases and Acute Kidney Injury in Patients With COVID-19: Evidence From a Meta-Analysis
por: Zhou, Yangzhong, et al.
Publicado: (2020)

Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
por: Putzke, Joerg, et al.
Publicado: (2021)

Trip Report on Control Systems in the U.S. Laboratories
por: Carpenter, B, et al.
Publicado: (1984)

Report on a visit to several U.S. laboratories
por: Mazzone, L
Publicado: (1969)

Three‐year U.S. pharmacovigilance report of brodalumab
por: Lebwohl, Mark, et al.
Publicado: (2021)

Acute kidney injury after COVID-19 vaccines: a real-world study
por: Luo, Huiting, et al.
Publicado: (2022)

Status Report on DA$\Phi$NE
por: Guiducci, S, et al.
Publicado: (2001)

Drug-induced tooth discoloration: An analysis of the US food and drug administration adverse event reporting system
por: Wang, Jun, et al.
Publicado: (2023)

Characteristics of adverse event reporting of Xeljanz/Xeljanz XR, Olumiant, and Rinvoq to the US Food and Drug Administration
por: Qian, Jingjing, et al.
Publicado: (2022)

$\omega$, $\varrho$ and $\phi$ production in $p$ + U, O + U and S + U collisions at 200 Gev/c
por: Abreu, M C, et al.
Publicado: (1990)

Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database
por: Nagai, Junko, et al.
Publicado: (2021)

Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration
por: Jones, Makoto M., et al.
Publicado: (2018)

The Significance of Information Posted on the U.S. Food and Drug Administration’s Website
por: Cook, G. Elliott, et al.
Publicado: (2013)

$\phi$ enhancement in S - U collisions at 200 GeV/nucleon
por: Bordalo, P, et al.
Publicado: (1992)

Hyperplastic Gastric Polyp Causing Upper Gastrointestinal Hemorrhage and Acute Blood Loss Anemia
por: Farooq, Aimen, et al.
Publicado: (2020)

Gastric Hyperplastic Polyp Causing Upper Gastrointestinal Hemorrhage and Severe Anemia in a Dog
por: Kim, Kihoon, et al.
Publicado: (2022)

Prevalence of Poor Mental Health Days and Adverse Childhood Experience Reporting in U.S. Adults Before and After COVID-19
por: Kapp, Julie M., et al.
Publicado: (2022)

Reporting of Foodborne Illness by U.S. Consumers and Healthcare Professionals
por: Arendt, Susan, et al.
Publicado: (2013)

Under-reporting of greenhouse gas emissions in U.S. cities
por: Gurney, Kevin Robert, et al.
Publicado: (2021)

Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data
por: Tang, Huilin, et al.
Publicado: (2021)

Improving risk prediction accuracy for new soldiers in the U.S. Army by adding self-report survey data to administrative data
por: Bernecker, Samantha L., et al.
Publicado: (2018)

Response to therapy at 6 months predicts long-term renal outcome in lupus nephritis with poor kidney function
por: Luo, Huiting, et al.
Publicado: (2022)

Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
por: Shimada, Kazuyo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l2rgrvbni7s1mdo422gegmjpk6